Nexien BioPharma, Inc (OTC: NXEN) Developing a cannabinoid-based drug pipeline.

November 14, 2018 admin CEO Interview, Healthcare Comments Off on Nexien BioPharma, Inc (OTC: NXEN) Developing a cannabinoid-based drug pipeline.
Alex Wasyl, CEO Nexien BioPharma

 

Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential!
Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of the crowd.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.

 

 

Alex Wasyl, CEO Nexien BioPharma

 

 

 

 

 

 

Nexien BioPharma, Inc (OTC: NXEN) CEO Interview with Alex Wasyl discussing the company’s cannabinoid-based drug development pipeline. Drug development targets include, epliepsy, myotonia and other markets.




Related Articles

Healthcare

CytoDyn (OTC: CYDY) Signs Definitive Agreements with Vyera Pharmaceuticals to Commercialize Leronlimab in the U.S. for the Treatment of HIV

December 17, 2019 admin Healthcare, Newsmakers Comments Off on CytoDyn (OTC: CYDY) Signs Definitive Agreements with Vyera Pharmaceuticals to Commercialize Leronlimab in the U.S. for the Treatment of HIV

VANCOUVER, Washington and NEW YORK, Dec 17, 2019 – In exchange for the exclusive right to market and distribute leronlimab in the U.S. for HIV-related indications, Vyera will pay upfront and regulatory and sales-based milestone […]

Consumer

Elixinol (OTC: ELLXF) U.S. Launch of Indulgent Hemp-Based Natural Skin Care Sativa Skincare’s Premium Products Uses Exotic Ingredients and are Cruelty-Free, Organic, Carbon Neutral, Vegan, Paraben-Free and Sulfate-Free

December 21, 2018 admin Consumer, Newsmakers Comments Off on Elixinol (OTC: ELLXF) U.S. Launch of Indulgent Hemp-Based Natural Skin Care Sativa Skincare’s Premium Products Uses Exotic Ingredients and are Cruelty-Free, Organic, Carbon Neutral, Vegan, Paraben-Free and Sulfate-Free

DENVER, Dec. 11, 2018  — US-based Elixinol (OTC: ELLXF)  announces the distribution of its first globally available, all-natural, hemp-based skin care and hair care line, Sativa. Get our FREE Newsletter! Discover Stocks with +1,000% Upside […]

Healthcare

Hoth Therapeutics (NASDQ: HOTH) to Attend Benchmark’s 8th Annual Discovery 1×1 Conference

November 18, 2019 admin Healthcare, Newsmakers Comments Off on Hoth Therapeutics (NASDQ: HOTH) to Attend Benchmark’s 8th Annual Discovery 1×1 Conference

NEW YORK, Nov. 18, 2019  — Hoth Therapeutics, Inc. (NASDAQ: HOTH) (“HOTH” or the “Company”), a biopharmaceutical company focused on developing new generation therapies for dermatological disorders such as atopic dermatitis, chronic wounds, psoriasis and acne, […]